20157 results for «»

Filter By

20157 results

What's on the Programme?

Developed by renowned specialists, the Programme covers the educational and training needs of imaging professionals, interventional cardiologists and NAPs
What's on the Programme?

Navigating complexity: surgical valve degeneration and complex coronary artery disease in a multimorbid patient

14 Dec 2023

How would you treat this 83-year-old male patient with LM, MVD, RCA CTO, severely reduced EF, and constrictive surgical valve?

Sadeek Sidney Kanoun Schnur

Author

Sadeek Sidney Kanoun Schnur

Author

Albrecht Schmidt
Dr. Gabor G. Toth

Author

Gabor G. Toth
Navigating complexity: surgical valve degeneration and complex CAD in a multimorbid patient

Our patient with a highly calcified vessel

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to define a step-by-step strategy to deal with calcified lesions, discover how OCT can support your decision making and to learn how to learn how to use ROTABLATOR for an effective and safe plaque debulking.

Our patient with a highly calcified vessel

Intracardiac echocardiography for tricuspid interventions

01 Dec 2023

Watch the replay of this webinar with R. Hahn, M. I. Koerber, S. Lim, F. Praz and R. S. Von Bardeleben to learn about the latest innovation for imaging the tricuspid valve and much more.

Intracardiac echocardiography for tricuspid interventions

Bifurcation PCI with provisional technique

15 May 2023 – From EAPCI-PCR Fellows course 2023

Consult these slides to learn how to assess bifurcation lesions, to get familiar with the steps of provisional approach and to understand causes and solutions for the most common pitfalls.

Bifurcation pci with provisional 

The catheter-based treatment revolution is just getting started

19 Nov 2023 – From PCR London Valves 2023

Consult this session to stay updated on the latest advancements in transcatheter aortic valve implantations and interventions for tricuspid regurgitation. Gain insights into how recent evidence and innovations are reshaping the treatment landscape for valvular heart disease.

The catheter-based treatment revolution is just getting started

The unimaginable evolution of interventional cardiology from imagination to imaging

07 Nov 2023

Faith is to believe what you do not see; the reward of this faith is to see what you believe... Read this editorial by Flavio Ribichini, Martine Gilard and Salvatore Brugaletta which introduces this section dedicated to cardiovascular imaging. ...

The unimaginable evolution of interventional cardiology from imagination to imaging

AHA 2023: get the interventional cardiology perspective!

11 Nov 2023

Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.

PCRonline @ AHA 2023

ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial

12 Nov 2023

Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
Christopher Rajkumar

Author

Christopher Rajkumar
Rasha Al-Lamee

Author

Rasha Al-Lamee
ORBITA-2 - Percutaneous coronary intervention for stable angina: A randomized, placebo-controlled trial

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

15 Nov 2023

Aaysha Cader interviews Peter Sinnaeve on the STREAM-2 1-year mortality follow-up results, which were presented at the AHA 2023 Congress in Philadelphia.
Results suggest that a pharmaco-invasive strategy provides an alternative for older STEMI patients unable to undergo primary PCI.

Author

Aaysha Cader
Peter Sinnaeve

Author

Peter Sinnaeve
Half-dose tenecteplase or primary PCI in older patients with ST-elevation myocardial infarction: The STREAM-2 1-year mortality follow-up results

TAVI and beyond: tackling coronary challenges

19 Nov 2023 – From PCR London Valves 2023

Consult this session to gain a comprehensive understanding of the crucial role of coronary access post-TAVI, and the impact of TAV design and implantation technique on coronary access. Gain some insights into the intricacies of coronary accessibility from extensive bench test work and the impact of TAV design in...

TAVI and beyond: tackling coronary challenges

Peter Sinnaeve

Leuven, Belgium

Peter Sinnaeve

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

19 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to understand the challenges of imaging for aortic regurgitation and how it can lead to underdiagnosis. Discover the data from the ALIGN-AR trial studying TAVI in aortic regurgitation patients, and learn about the Trilogy valve and the future of TAVI...

A problem and a solution: aortic regurgitation and the Trilogy TAVI valve

INDUSTRY PARTNERS HELPED MAKE IT HAPPEN!

Before, during and after EuroPCR, Industry Partners provide precious support with content and initiatives that contribute to making this event the World-Leading Course in Interventional Cardiovascular Medicine.
INDUSTRY PARTNERS HELPED MAKE IT HAPPEN!

Dominic Allocco

Edina, United States of America

Srinivas B C

BANGALORE, India

Mei Chau

New York, United States of America

Luigi Ferrarotto

Pedara, Italy

Marcin Fijalkowski

Gdansk, Poland

Didn’t find what you were looking for?